SCHEMBL466560

SCHEMBL466560

Cc1cc(CCC(=O)OCCOCCOCCOC(=O)CCc2cc(C)cc(C(C)(C)C)c2O)c(O)c(C(C)(C)C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPA5 P11021 2/20 0.53
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
HIF1A Q16665 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
CYP2D6 P10635 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ALDH1A1 P00352 1/20 0.45
CA2 P00918 1/20 0.45
POLB P06746 1/20 0.45
TYR P14679 1/20 0.45
GAA P10253 2/20 0.36
SERPINE1 P05121 1/20 0.35
APP P05067 1/20 0.35
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35
VCAM1 P19320 2/20 0.34
ALOX5 P09917 1/20 0.34
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30115160 1.00 HSPA5 (0.53) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL3173292 0.96 HSPA5 (0.57) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL29200155 0.95 HSPA5 (0.48) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL31279673 0.95 HSPA5 (0.50) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL15703447 0.91 HSPA5 (0.51) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL7940083 0.91 HSPA5 (0.51) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL3809307 0.88 HSPA5 (0.49) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL11817566 0.86 GAA (0.38) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL30862169 0.85 HSPA5 (0.57) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2
SCHEMBL18998954 0.84 HSPA5 (0.51) HSPA5CYP2C9CYP2C19HIF1ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 399 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12638399-B2 Method for determining total aldehydes in one or more of crude 2,5-furandicarboxylic acid (FDCA), crude terephthalic acid (TPA) and esters of these ARCHER-DANIELS-MIDLAND COMPANY (US) 2026-05-26 US claimed
WO-2026099121-A1 A HOT-MELT ADHESIVE HAVING IMPROVED HEAT STABILITY SIKA TECHNOLOGY AG (CH) 2026-05-15 WO claimed
EP-4741467-A1 A HOT-MELT ADHESIVE HAVING IMPROVED HEAT STABILITY Sika Technology AG (CH) 2026-05-13 EP claimed
EP-4162266-B1 METHOD FOR DETERMINING TOTAL ALDEHYDES IN ONE OR MORE OF CRUDE 2,5-FURANDICARBOXYLIC ACID (FDCA), CRUDE TEREPHTHALIC ACID (TPA) AND ESTERS OF THESE ARCHER DANIELS MIDLAND CO (US) 2025-06-25 EP claimed
CN-120082016-A Bio-based polyurethane acrylic resin with low water absorption and preparation method thereof 湖大粤港澳大湾区创新研究院(广州增城) 2025-06-03 CN claimed
CN-120040877-A Polypropylene material and preparation method and application thereof 金发科技股份有限公司 2025-05-27 CN claimed
US-12305034-B2 Automobile interior component made from polyacetal resin POLYPLASTICS CO., LTD. (JP) 2025-05-20 US claimed
CN-119923245-A Stable skin care compositions comprising retinoids 宝洁公司 2025-05-02 CN claimed
US-12258325-B2 Color stabilization of monomers and other reactants for forming bio-based polymers ARCHER DANIELS MIDLAND COMPANY (US) 2025-03-25 US claimed
CN-119053651-A Aqueous antioxidant suspension emulsion and preparation method thereof 巴斯夫欧洲公司 2024-11-29 CN claimed
CN-118027558-A Polypropylene compound and preparation method and application thereof 金发科技股份有限公司 2024-05-14 CN claimed
US-20240060902-A1 METHOD FOR DETERMINING TOTAL ALDEHYDES IN ONE OR MORE OF CRUDE 2,5-FURANDICARBOXYLIC ACID (FDCA), CRUDE TEREPHTHALIC ACID (TPA) AND ESTERS OF THESE ARCHER DANIELS MIDLAND CO (US) 2024-02-22 US claimed
CN-116940828-A Method for determining total aldehydes in one or more of crude 2, 5-furandicarboxylic acid (FDCA), crude terephthalic acid (TPA), and esters thereof 阿彻丹尼尔斯米德兰德公司 2023-10-24 CN claimed
EP-3263645-B1 RESIN COMPOSITION AND ARTICLE MOLDED THEREFROM MITSUBISHI CHEM CORP (JP) 2023-10-11 EP claimed
EP-4162266-A1 METHOD FOR DETERMINING TOTAL ALDEHYDES IN ONE OR MORE OF CRUDE 2,5-FURANDICARBOXYLIC ACID (FDCA), CRUDE TEREPHTHALIC ACID (TPA) AND ESTERS OF THESE Archer Daniels Midland Company (US) 2023-04-12 EP claimed
CN-113002085-B Optical active device and preparation method thereof 浙江精一新材料科技有限公司 2023-04-07 CN claimed
CN-114269805-A Process for preparing polyisocyanate compositions 韩华思路信(株) 2022-04-01 CN claimed
US-10800901-B2 Resin composition and article molded therefrom MITSUBISHI CHEMICAL CORPORATION (JP) 2020-10-13 US claimed
US-20180030240-A1 Resin Composition and Article Molded Therefrom MITSUBISHI CHEMICAL CORPORATION (JP) 2018-02-01 US claimed
EP-3263645-A1 RESIN COMPOSITION AND ARTICLE MOLDED THEREFROM Mitsubishi Chemical Corporation (JP) 2018-01-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12638399-B2 Method for determining total aldehydes in one or more of crude 2,5-furandicarboxylic acid (FDCA), crude terephthalic acid (TPA) and esters of these FTO, AOC1, AOC2 HSPA5 2328/4885CYP2C9 611/4885CYP2C19 1325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.